Assistant professor at Hormel Institute earns $789,000 grant for four-year study of lung cancer.
Written By:
Post Bulletin staff reports | 2:56 pm, May 18, 2021 ×
Dr. Luke Hoeppner
AUSTIN Dr. Luke Hoeppner, assistant professor and leader of the Cancer Biology lab at the Hormel Institute, was named a recipient of an American Cancer Society Research Scholar Grant.
Hoeppner was awarded $789,000 to conduct a four-year study focusing on a deadly form of lung cancer. I am driven to research small-cell lung cancer because it is a particularly aggressive disease and difficult to treat, said Hoeppner. My uncle was diagnosed with advanced stage small cell lung cancer and very little could be done for him through existing therapies before he unfortunately passed away. I am extremely thankful for this American Cancer Society funding because it allows me to pursue a new lung cancer research direction that otherwise would not be possible.
Hormel Foods and Hormel Institute hope to continue working relationship
Photo courtesy of The Hormel Institute.
Senior Hormel VP visits Institute on Monday.
Posted: May 4, 2021 12:34 PM
Posted By: Mike Bunge
AUSTIN, Minn. – Hormel Foods and The Hormel Institute met Monday on continuing their productive relationship.
The Fortune 500 company and the cancer research organization have worked together on projects like the Hormel Vital Cuisine brand, a line of convenient, high-protein shakes, meals and whey powders designed for people who are undergoing treatment or recovering from diseases such as cancer.
The meeting involved Dr. Kevin Myers, Senior Vice President of Research and Development and Quality Control at Hormel Foods, visiting The Hormel Institute and meeting with Dr. Robert Clarke, The Hormel Institute’s Executive Director and head of the Cancer Systems Biology lab and professor of Biochemistry, Molecular Biology and Biophysics at the University of Minnesota, and D
Pharmaceutical Ingredients Manufacturer Nu-Tek BioSciences Announces Plans To Build New Facility In Minnesota
Nu-Tek BioSciences, an innovative manufacturer of industrial ingredients used in the development and manufacturing of pharmaceuticals, will build a new manufacturing facility in Austin, Minnesota.
The project will be the first dedicated, animal-free peptone, and protein hydrolysate manufacturing facility in the U.S. This U.S. owned peptone manufacturing plant will help meet the rapidly growing demand for materials used to manufacture biologics.
Nu-Tek is currently supplying a critical component used in the manufacture of a COVID-19 vaccine. According to company officials, this investment into manufacturing comes at a time when pharmaceutical companies are seeking solutions to mitigate supply chain risk. With the current pressures of COVID-19 vaccine manufacturing, this capacity will solidify the Company’s commitment to building businesses and assets with long-term sustai